glutathione and triple negative breast cancer Frontiers GPX4 in triple-negative breast cancer:
GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect A review of biological targets and therapeutic approaches in the management of triple negative breast cancer ScienceDirect Interaction of glaucocalyxin a with glutathione and thioredoxin reductase for triple negative breast cancer treatment ScienceDirect Heterogeneity and transcriptional drivers of triple negative breast cancer: Cell Reports Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy: Cell Metabolism
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 13 - Sep 18




